HIV-associated changes in the enteric microbial community: potential role in loss of homeostasis and development of systemic inflammation
- PMID: 27922852
- PMCID: PMC5325247
- DOI: 10.1097/QCO.0000000000000341
HIV-associated changes in the enteric microbial community: potential role in loss of homeostasis and development of systemic inflammation
Abstract
Purpose of review: Despite HIV therapy advances, average life expectancy in HIV-infected individuals on effective treatment is significantly decreased relative to uninfected persons, largely because of increased incidence of inflammation-related diseases, such as cardiovascular disease and renal dysfunction. The enteric microbial community could potentially cause this inflammation, as HIV-driven destruction of gastrointestinal CD4 T cells may disturb the microbiota-mucosal immune system balance, disrupting the stable gut microbiome and leading to further deleterious host outcomes.
Recent findings: Varied enteric microbiome changes have been reported during HIV infection, but unifying patterns have emerged. Community diversity is decreased, similar to pathologies such as inflammatory bowel disease, obesity, and Clostridium difficile infection. Many taxa frequently enriched in HIV-infected individuals, such as Enterobacteriaceae and Erysipelotrichaceae, have pathogenic potential, whereas depleted taxa, such as Bacteroidaceae and Ruminococcaceae, are more linked with anti-inflammatory properties and maintenance of gut homeostasis. The gut viral community in HIV has been found to contain a greater abundance of pathogenesis-associated Adenoviridae and Anelloviridae. These bacterial and viral changes correlate with increased systemic inflammatory markers, such as serum sCD14, sCD163, and IL-6.
Summary: Enteric microbial community changes may contribute to chronic HIV pathogenesis, but more investigation is necessary, especially in the developing world population with the greatest HIV burden (Video, Supplemental Digital Content 1, http://links.lww.com/COID/A15, which includes the authors' summary of the importance of the work).
Figures
Similar articles
-
Gut barrier structure, mucosal immunity and intestinal microbiota in the pathogenesis and treatment of HIV infection.AIDS Res Ther. 2016 Apr 11;13:19. doi: 10.1186/s12981-016-0103-1. eCollection 2016. AIDS Res Ther. 2016. PMID: 27073405 Free PMC article. Review.
-
Intestinal microbiota, microbial translocation, and systemic inflammation in chronic HIV infection.J Infect Dis. 2015 Jan 1;211(1):19-27. doi: 10.1093/infdis/jiu409. Epub 2014 Jul 23. J Infect Dis. 2015. PMID: 25057045 Free PMC article.
-
Oral and Gut Microbial Diversity and Immune Regulation in Patients with HIV on Antiretroviral Therapy.mSphere. 2020 Feb 5;5(1):e00798-19. doi: 10.1128/mSphere.00798-19. mSphere. 2020. PMID: 32024712 Free PMC article.
-
Altered gut microbiome composition in HIV infection: causes, effects and potential intervention.Curr Opin HIV AIDS. 2018 Jan;13(1):73-80. doi: 10.1097/COH.0000000000000429. Curr Opin HIV AIDS. 2018. PMID: 29045252 Review.
-
Microbiome of HIV-infected people.Microb Pathog. 2017 May;106:85-93. doi: 10.1016/j.micpath.2016.05.015. Epub 2016 May 20. Microb Pathog. 2017. PMID: 27216237 Review.
Cited by
-
Long-Term Suppressive cART Is Not Sufficient to Restore Intestinal Permeability and Gut Microbiota Compositional Changes.Front Immunol. 2021 Feb 26;12:639291. doi: 10.3389/fimmu.2021.639291. eCollection 2021. Front Immunol. 2021. PMID: 33717191 Free PMC article.
-
Major depletion of insulin sensitivity-associated taxa in the gut microbiome of persons living with HIV controlled by antiretroviral drugs.BMC Med Genomics. 2024 Aug 13;17(1):209. doi: 10.1186/s12920-024-01978-5. BMC Med Genomics. 2024. PMID: 39138568 Free PMC article.
-
Management of HIV-infected patients in the intensive care unit.Intensive Care Med. 2020 Feb;46(2):329-342. doi: 10.1007/s00134-020-05945-3. Epub 2020 Feb 3. Intensive Care Med. 2020. PMID: 32016535 Free PMC article. Review.
-
Incomplete immune reconstitution in HIV/AIDS patients on antiretroviral therapy: Challenges of immunological non-responders.J Leukoc Biol. 2020 Apr;107(4):597-612. doi: 10.1002/JLB.4MR1019-189R. Epub 2020 Jan 22. J Leukoc Biol. 2020. PMID: 31965635 Free PMC article. Review.
-
Cellular and molecular insights into incomplete immune recovery in HIV/AIDS patients.Front Immunol. 2023 May 2;14:1152951. doi: 10.3389/fimmu.2023.1152951. eCollection 2023. Front Immunol. 2023. PMID: 37205108 Free PMC article. Review.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials